Free Trial

Crescita Therapeutics (CTX) Insider Trading & Ownership

Crescita Therapeutics logo
C$0.58 +0.01 (+1.75%)
As of 01/17/2025 10:39 AM Eastern

Crescita Therapeutics (TSE:CTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.87%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
C$51,436.60
Number Of
Insiders Selling
(Last 12 Months)
0
Get CTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Crescita Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CTX Insider Buying and Selling by Quarter

Crescita Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/27/2024Jose DarochaDirectorBuy86,000C$0.60C$51,436.60
(Data available from 1/1/2013 forward)

CTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Crescita Therapeutics includes Anthony Edward Dobranowski, and Jose Darocha. Learn more on insiders at CTX.

10.87% of Crescita Therapeutics stock is owned by insiders. Learn more on CTX's insider holdings.

The following insider purchased CTX shares in the last 24 months: Jose Darocha (C$65,841.60).

Insiders have purchased a total of 119,500 CTX shares in the last 24 months for a total of C$65,841.60 bought.

Crescita Therapeutics Key Executives

  • Mr. Serge Verreault B.A.
    M.B.A., President, CEO & Director
  • Mr. Jose DaRocha C.A.
    CPA, Chief Financial Officer
    1 recent trades
  • Mr. Francois Lafortune
    Executive VP & GM


This page (TSE:CTX) was last updated on 1/19/2025 by MarketBeat.com Staff
From Our Partners